Lupus Nephritis Clinical Trials in New York, New York

8 studies are recruiting for lupus nephritis in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. VIBRANT: VIB4920 for Active Lupus Nephritis

   This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in participants with active lupus nephritis (LN).

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Columbia University Medical Center: Department of Medicine, Division of Rheumatology, New York, New York

   Locations

   17 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT05201469 on ClinicalTrials.gov

2. The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

   The study is a 1-year 2-part double-blinded placebo controlled 2-arm clinical trial. Treatment arms are (1) MMF dosed as per body-surface area (MMFBSA; 600mg/m2 body surface area per dose about every 12 hours) and (2) pharmacokinetically-guided precision-dosing of MMF (MMFPK; MMF dosed twice daily …

   Stage

   Phase 2

   Ages

   8 to 20

   Site

   Hospital for Special Surgery, New York, New York

   Locations

   19 in total

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT05538208 on ClinicalTrials.gov

3. RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

   RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

   Stage

   Phase 1

   Ages

   18 to 65

   Site

   Columbia University Irving Medical Center, New York, New York

   Locations

   23 in total

   Run by

   Cabaletta Bio

   See if you can join NCT06121297 on ClinicalTrials.gov

4. Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

   The purpose of this trial is to evaluate the efficacy and safety of obecabtagene autoleucel (obe-cel) administered once following lymphodepletion in participants with severe, refractory systemic lupus erythematosus (SLE) and active lupus nephritis (LN).

   Stage

   Phase 2

   Ages

   12 to 65

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Locations

   15 in total

   Run by

   Autolus Limited

   See if you can join NCT07053800 on ClinicalTrials.gov

5. A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

   This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Nkarta Investigational Site, New York, New York

   Locations

   19 in total

   Run by

   Nkarta, Inc.

   See if you can join NCT06557265 on ClinicalTrials.gov

6. A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

   This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants with moderate-to-severe active systemic lupus erythematosus (SLE) with or without nephritis, antine…

   Stage

   Phase 1

   Ages

   12 to 70

   Site

   Montefiore Medical Center, New York, New York

   Locations

   21 in total

   Run by

   Fate Therapeutics

   See if you can join NCT06308978 on ClinicalTrials.gov

7. Lupus Landmark Study: A Prospective Registry and Biorepository

   The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

   Stage

   Not phased

   Ages

   18 to 110

   Site

   Northwell Health, New York, New York

   Locations

   25 in total

   Run by

   Lupus Research Alliance

   See if you can join NCT05934149 on ClinicalTrials.gov

8. Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

   A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to …

   Stage

   Not phased

   Ages

   18 and older

   Site

   The Rogosin Institute, New York, New York

   Run by

   The Rogosin Institute

   See if you can join NCT01802034 on ClinicalTrials.gov